Home » Topics » Regulatory » Patents

Patents
RSS

New PROTACs targeting androgen receptors sythesized at Sichuan Haisco Pharmaceutical

Feb. 1, 2022

New ENPP2 inhibitors identified at Suzhou Ark Biopharmaceutical

Feb. 1, 2022

Chengdu Fanxi Biopharma identifies PPAR-alpha and/or PPAR-delta agonists

Jan. 31, 2022

Shanghai Institute of Materia Medica patents glucose-lowering agents

Jan. 31, 2022

New IL-17RA antagonists presented by Hitgen

Jan. 31, 2022

New MET/MERTK/TRYO3/AXL inhibitors identified at Aucentra Therapeutics

Jan. 31, 2022

Betta Pharmaceuticals discovers CD73 inhibitors

Jan. 31, 2022

BioWorld MedTech Patent Highlights: Week 3

From Current Patent Gazette

Jan. 28, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Chinese researchers discover new SST2 receptor ligands

Jan. 28, 2022

Bacainn Therapeutics synthesizes new NLRP inflammasome inhibitors

Jan. 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...